Financial Incentives for Smoking Cessation

ID: NCT00128375
Status: Completed
Phase: N/A
Start Date: March 01, 2005
First Submitted: August 08, 2005
Last Updated: December 12, 2007
Results: N/A
Sponsors & Collaborators: University of Pennsylvania, Centers for Disease Control and Prevention
Location: United States
Conditions: Tobacco Use Disorder
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

Study Description

Brief Summary

The purpose of this study is to test the effectiveness of financial incentives for increasing long-term smoking cessation rates among employees at General Electric worksites throughout the United States.

Detailed Description

Smoking is the leading cause of preventable mortality in United States, accounting for approximately 435,000 of the 2.4 million deaths each year in the United States. Most smokers make multiple attempts to quit smoking, but only 2-3% succeed each year. Smoking cessation programs have proven effective in helping smokers quit, but only about 5% of smokers enroll in smoking cessation programs each year.

Financial incentives have been shown to increase enrollment in smoking cessation programs and short-term quit rates, but have not been well tested as a mechanism for increasing long-term quit rates. The existing evidence suggests that they could be highly effective, particularly among heavy smokers and low income smokers. In addition, financial incentives for smoking cessation will likely be more cost effective than most covered health services and at least as cost effective as other recommended smoking cessation treatments.

This study is a two-arm randomized clinical trial of financial incentives for smoking cessation among a sample of 850 male and female smokers from GE Energy worksites throughout the U.S. Smokers will be randomized to receive either usual care (information about local community-based smoking cessation resources, coverage of prescription drugs and physician visits) or usual care plus a package of financial incentives that includes $100 for completion of a community-based tobacco cessation program, $250 for short-term smoking cessation at either 3 months or 6 months after randomization, and $400 for smoking cessation 6 months post-quit date (biochemically confirmed).
Condition or disease Intervention/treatment Phase

Tobacco Use Disorder

Behavioral: Financial incentives
Other Names
N/A

Tracking Information

First Submitted DateAugust 08, 2005
Last Update Posted DateDecember 12, 2007
Start DateMarch 01, 2005
Completion DateApril 01, 2008
Primary Completion DateN/A
Results First Submitted DateN/A
Received Results Disposit DateN/A

Current Primary Outcome Measures

  • Biochemically verified smoking cessation rates at 6 months post-quit date

Original Primary Outcome Measures

Not Available

Current Secondary Outcome Measures

  • Enrollment in and completion of community-based smoking cessation programs within the first 6 months after randomization

  • Short-term quit rates at 3 months or 6 months post-quit date

  • Quit rates at 12 months post-quit date

Original Secondary Outcome Measures

Not Available

Study Design

Brief TitleFinancial Incentives for Smoking Cessation
Official TitleFinancial Incentives for Smoking Cessation
Brief Summary

The purpose of this study is to test the effectiveness of financial incentives for increasing long-term smoking cessation rates among employees at General Electric worksites throughout the United States.

Detailed Description

Smoking is the leading cause of preventable mortality in United States, accounting for approximately 435,000 of the 2.4 million deaths each year in the United States. Most smokers make multiple attempts to quit smoking, but only 2-3% succeed each year. Smoking cessation programs have proven effective in helping smokers quit, but only about 5% of smokers enroll in smoking cessation programs each year.

Financial incentives have been shown to increase enrollment in smoking cessation programs and short-term quit rates, but have not been well tested as a mechanism for increasing long-term quit rates. The existing evidence suggests that they could be highly effective, particularly among heavy smokers and low income smokers. In addition, financial incentives for smoking cessation will likely be more cost effective than most covered health services and at least as cost effective as other recommended smoking cessation treatments.

This study is a two-arm randomized clinical trial of financial incentives for smoking cessation among a sample of 850 male and female smokers from GE Energy worksites throughout the U.S. Smokers will be randomized to receive either usual care (information about local community-based smoking cessation resources, coverage of prescription drugs and physician visits) or usual care plus a package of financial incentives that includes $100 for completion of a community-based tobacco cessation program, $250 for short-term smoking cessation at either 3 months or 6 months after randomization, and $400 for smoking cessation 6 months post-quit date (biochemically confirmed).

Study TypeInterventional
Study PhaseN/A
Estimated Enrollment
878
Allocation
Randomized
Interventional Model
Parallel Assignment
Masking
None
Primary Purpose
Prevention
Conditions
Tobacco Use Disorder
Target Follow-Up Duration N/A
Biospecimen:
N/A
Sampling MethodN/A
Study PopulationN/A
Intervention
Behavioral: Financial incentives

Other Names
Study Groups/Cohorts
Not Available
Study Arms
Not Available
Arm Intervention/Treatment

Recruitment Information

Recruitment Status:Completed
Enrollment878
Completion DateApril 01, 2008
Eligibility Criteria: Inclusion Criteria:
- Employees of General Electric at work sites in the United States
- Current smokers who report having smoked at least 5 cigarettes per day for the prior 12 months
- Age 18 or older

Exclusion Criteria:
- Current use of other tobacco products, such as chewing tobacco, pipes, or cigars
- Planning to leave General Electric within the next 18 months
GenderAll
Age18 Years to N/A
Accepts Healthy VolunteersNo
Contacts
Not Available
Listed Location Countries
United States

Administrative Information

NCT Number:NCT00128375
Other Study ID Numbers
802295
1R01DP000100-03
Has Data Monitoring CommitteeNo
U.S. FDA-regulated Product Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Device Product Not Approved or Cleared by U.S. FDA: No
IPD Sharing Statement
Not Available
Responsible PartyN/A
Study Sponsor
University of Pennsylvania
Collaborators
Centers for Disease Control and Prevention
Investigators
Principal Investigator
Kevin G Volpp, MD, PhD
University of Pennsylvania